These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10401760)

  • 1. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts.
    Simonson MS; Herman WH; Robinson A; Schulak J; Hricik DE
    Transplantation; 1999 Jun; 67(12):1542-7. PubMed ID: 10401760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
    Simonson MS; Robinson AV; Schulak JA; Hricik DE
    Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pravastatin on chronic rejection of rat cardiac allografts.
    Maggard MA; Ke B; Wang T; Kaldas F; Seu P; Busuttil RW; Imagawa DK
    Transplantation; 1998 Jan; 65(2):149-55. PubMed ID: 9458006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.
    Watschinger B; Sayegh MH; Hancock WW; Russell ME
    Am J Pathol; 1995 May; 146(5):1065-72. PubMed ID: 7747801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
    Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Yard B; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    Transplantation; 1999 Sep; 68(6):739-46. PubMed ID: 10515373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model.
    Knight RJ; Dikman S; Liu H; Martinelli GP
    Transplantation; 1997 Oct; 64(8):1102-7. PubMed ID: 9355823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of endothelin-1 and endothelin-converting enzyme-1 in rat lung allografts.
    McDermott CD; Shennib H; Giaid A
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S27-30. PubMed ID: 9595391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplantation; 1995 Oct; 60(7):729-33. PubMed ID: 7570985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model.
    Adams DH; Russell ME; Hancock WW; Sayegh MH; Wyner LR; Karnovsky MJ
    Immunol Rev; 1993 Aug; 134():5-19. PubMed ID: 8225375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):428-37. PubMed ID: 11026642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
    Chen H; Wu J; Xu D; Luo H; Daloze PM
    Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.
    Adams J; Odoni G; Ogata H; Viedt C; Amann K; Ritz E; Orth SR
    Nephrol Dial Transplant; 2002 May; 17(5):780-7. PubMed ID: 11981063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats.
    Gulati A; Singh R; Chung SM; Sen AP
    J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1, endothelin-3 and their receptors (endothelin(A) and endothelin(B)) in chronic renal transplant rejection in rats.
    Deng DX; Jiang J; Garcia B; Zhong R; Chakrabarti S
    Transpl Int; 2000; 13(3):175-82. PubMed ID: 10935699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts.
    Tori M; Kitagawa-Sakakida S; Li Z; Izutani H; Horiguchi K; Ito T; Matsuda H; Shirakura R
    Transplantation; 2000 Sep; 70(5):737-46. PubMed ID: 11003350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.